A First or Dominant Immunization. I. Suppression of Simultaneous Cytolytic T Cell Responses to Unrelated Alloantigens

Overview

Journal J Exp Med

Specialties Allergy & Immunology
General Medicine

Date 1993 Sep 1

PMID 8350057

Citations 5

Authors

D A Rowley

R M Stach

Affiliations

Soon will be listed here.

Abstract

A first or dominant immunization with one antigen markedly inhibited specific cytolytic T lymphocyte (CTL) responses to a second unrelated alloantigen without suppressing antibody responses to other antigens. Suppression was induced rapidly, became systemic, and could be transferred passively with only serum. Suppression did not result from elimination of cells capable of responding to the second antigen. The mechanisms responsible for this "priority of the first response" may be the same that help protect the fetus during pregnancy, promote renal allograft survival after multiple blood transfusions, and prevent effective CTL-mediated immunity to variants of tumor cells or infectious agents that arise during tumor progression or chronic infections.

Citing Articles

Neoadjuvant PD-1 Immune Checkpoint Blockade Reverses Functional Immunodominance among Tumor Antigen-Specific T Cells.

Friedman J, Moore E, Zolkind P, Robbins Y, Clavijo P, Sun L Clin Cancer Res. 2019; 26(3):679-689.

PMID: 31645352 PMC: 7002203. DOI: 10.1158/1078-0432.CCR-19-2209.

Circulating immunoglobulin-bound transforming growth factor beta at a late tumour-bearing stage impairs antigen-specific responses of CD4+ T cells.

Harada M, Tatsugami K, Nomoto M, Nomoto K Clin Exp Immunol. 2002; 128(2):204-12.

PMID: 12041507 PMC: 1906390. DOI: 10.1046/j.1365-2249.2002.01806.x.

T cell receptor usage and fine specificity of human immunodeficiency virus 1-specific cytotoxic T lymphocyte clones: analysis of quasispecies recognition reveals a dominant response directed against a minor in vivo variant.

Kalams S, Johnson R, Dynan M, Hartman K, Harrer T, Harrer E J Exp Med. 1996; 183(4):1669-79.

PMID: 8666925 PMC: 2192525. DOI: 10.1084/jem.183.4.1669.

A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens.

Stach R, Rowley D J Exp Med. 1993; 178(3):841-52.

PMID: 8350058 PMC: 2191145. DOI: 10.1084/jem.178.3.841.

Autoantibodies produced spontaneously by young 1pr mice carry transforming growth factor beta and suppress cytotoxic T lymphocyte responses.

Rowley D, Becken E, Stach R J Exp Med. 1995; 181(5):1875-80.

PMID: 7722461 PMC: 2192013. DOI: 10.1084/jem.181.5.1875.

References

Schechter I . Antigenic competition between polypeptidyl determinants in normal and tolerant rabbits. J Exp Med. 1968; 127(2):237-50. PMC: 2138447. DOI: 10.1084/jem.127.2.237. View

Torre-Amione G, Tuetken R, Rowley D . Powerful immunosuppression mediated by interleukin 2-activated, nonantigen-specific, or H-2-restricted THY-1+ CD8+ cells. Cell Immunol. 1989; 124(1):50-63. DOI: 10.1016/0008-8749(89)90111-1. View

Albright J, Omer T, Deitchman J . Antigen competition: antigens compete for a cell occurring with limited frequency. Science. 1970; 167(3915):196-8. DOI: 10.1126/science.167.3915.196. View

Waterston R . Antigen competition: a paradox. Science. 1970; 170(3962):1108-10. DOI: 10.1126/science.170.3962.1108. View

Moller G, Sjoberg O . Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol. 1970; 1(1):110-21. DOI: 10.1016/0008-8749(70)90064-x. View

Rowley D, Kohler H, Schreiber H, Kaye S, Lorbach I . Suppression by autogenous complementary idiotypes: the priority of the first response. J Exp Med. 1976; 144(4):946-59. PMC: 2190429. DOI: 10.1084/jem.144.4.946. View

Opelz G, Terasaki P . Improvement of kidney-graft survival with increased numbers of blood transfusions. N Engl J Med. 1978; 299(15):799-803. DOI: 10.1056/NEJM197810122991503. View

Taylor C, Faulk W . Prevention of recurrent abortion with leucocyte transfusions. Lancet. 1981; 2(8237):68-70. DOI: 10.1016/s0140-6736(81)90413-x. View

Beer A, Quebbeman J, Ayers J, HAINES R . Major histocompatibility complex antigens, maternal and paternal immune responses, and chronic habitual abortions in humans. Am J Obstet Gynecol. 1981; 141(8):987-99. DOI: 10.1016/s0002-9378(16)32690-4. View

10.

Urban J, Burton R, Holland J, Kripke M, Schreiber H . Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells. J Exp Med. 1982; 155(2):557-73. PMC: 2186599. DOI: 10.1084/jem.155.2.557. View

11.

Ria F, Chan B, Scherer M, Smith J, Gefter M . Immunological activity of covalently linked T-cell epitopes. Nature. 1990; 343(6256):381-3. DOI: 10.1038/343381a0. View

12.

Heyman B . Fc-dependent IgG-mediated suppression of the antibody response: fact or artefact?. Scand J Immunol. 1990; 31(5):601-7. DOI: 10.1111/j.1365-3083.1990.tb02811.x. View

13.

Ward P, Koeppen H, Hurteau T, Rowley D, Schreiber H . Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance. Cancer Res. 1990; 50(13):3851-8. View

14.

Leclerc C, Schutze M, Deriaud E, Przewlocki G . The in vivo elimination of CD4+ T cells prevents the induction but not the expression of carrier-induced epitopic suppression. J Immunol. 1990; 145(5):1343-9. View

15.

Pircher H, Moskophidis D, Rohrer U, Burki K, Hengartner H, Zinkernagel R . Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature. 1990; 346(6285):629-33. DOI: 10.1038/346629a0. View

16.

Galelli A, Charlot B . Clonal anergy of memory B cells in epitope-specific regulation. J Immunol. 1990; 145(8):2397-405. View

17.

Phillips R, Rowland-Jones S, Nixon D, Gotch F, Edwards J, Ogunlesi A . Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991; 354(6353):453-9. DOI: 10.1038/354453a0. View

18.

Stach R, Rowley D . A first or dominant immunization. II. Induced immunoglobulin carries transforming growth factor beta and suppresses cytolytic T cell responses to unrelated alloantigens. J Exp Med. 1993; 178(3):841-52. PMC: 2191145. DOI: 10.1084/jem.178.3.841. View

19.

van Rood J, EERNISSE J, van Leeuwen A . Leucocyte antibodies in sera from pregnant women. Nature. 1958; 181(4625):1735-6. DOI: 10.1038/1811735a0. View

20.

Herzenberg L, Tokuhisa T . Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses. J Exp Med. 1982; 155(6):1730-40. PMC: 2186699. DOI: 10.1084/jem.155.6.1730. View